|
HS Code |
143217 |
| Productname | 8-Bromo-4-(1H)-Quinazolinone |
| Casnumber | 25462-88-2 |
| Molecularformula | C8H5BrN2O |
| Molecularweight | 225.04 g/mol |
| Appearance | Off-white to light yellow powder |
| Meltingpoint | 242-245°C |
| Solubility | Slightly soluble in water, soluble in DMSO and methanol |
| Purity | Typically ≥98% |
| Storageconditions | Store at 2-8°C, protected from light |
| Synonyms | 8-Bromoquinazolin-4(3H)-one |
| Iupacname | 8-Bromo-3,4-dihydroquinazolin-4-one |
| Smiles | Brc1cccc2c(=O)ncnc12 |
| Inchikey | ZQPUDBIHYBIVTG-UHFFFAOYSA-N |
| Hazardstatements | May cause irritation to eyes, skin, and respiratory tract |
As an accredited 8-Bromo-4-(1H)-Quinazolinone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 8-Bromo-4-(1H)-Quinazolinone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in research, you get to know which molecules can open up new directions in a project and which ones just clog up a lab shelf. 8-Bromo-4-(1H)-Quinazolinone falls squarely in the first group. A lot of people in pharmaceutical labs and at universities keep reaching for quinazolinone derivatives, and for good reason. The 8-bromo version isn’t just another option—it packs some real advantages. Just by changing a small part of the molecule, its behavior changes in measurable and meaningful ways.
Taking stock of the basic features helps right away. This compound sits in the family of quinazolinones—a core structure chemists link to everything from anti-cancer agents to agricultural products. By substituting a bromine atom at the 8-position, you get 8-Bromo-4-(1H)-Quinazolinone, which is no simple marker of novelty. The bromine atom brings unique reactivity. Synthetic chemists often need that specific position to be reactive for further transformations—think of Suzuki couplings, Buchwald-Hartwig aminations, or halogen-metal exchange. If you’re trying to build a diverse library of compounds, or want to test something that can be precisely tweaked for biological research, having a bromo group opens up opportunities that plain quinazolinone simply can’t.
This model—sometimes recognized in catalogs as 8-Bromoquinazolin-4(1H)-one—usually enters the market in a solid, off-white form. Its purity and consistency have improved significantly over the last decade, especially as suppliers respond to stricter needs in pharmaceutical screening and small-molecule probe development. Purities tend to exceed 98%, reflecting both the increasingly sophisticated needs of modern applications and a tightening of quality controls by reputable suppliers. The molecule’s stability, on a typical shelf in a dry, shaded spot, assures repeatable performance project by project. Mixtures or unpredictable decomposition aren’t concerns anyone wants in a research setting, and with this compound, they generally don’t show up.
During my graduate years, several projects came down to the availability and versatility of specialized building blocks. Quinazolinone scaffolds played a role in more than one. 8-Bromo-4-(1H)-Quinazolinone let my team tap into continual advances in heterocyclic chemistry. Medicinal chemists searching for kinase inhibitors, for example, need substituents positioned just so on their molecular frameworks. A bromine at the 8-position makes it possible to precisely click on different groups to see how small changes alter activity in biological assays. Research groups tackling neurodegenerative disease models, infectious pathogens, and even crop protection have also relied on similar quinazolinones, often probing small differences in bioavailability or selectivity that a halogen atom can tweak.
Unlike many static molecular skeletons, quinazolinone derivatives like this one supply a modular platform for exploration. With a simple halogen present, the scope for cross-coupling reactions widens, and that changes the way chemists approach problem solving. Instead of needing a suite of custom reagents, teams can diversify with a handful of starting points. I’ve sat in meetings where a single brominated quinazolinone replaced hours of unpredictable indole or pyrimidine chemistry, just by letting a coupling reaction work as advertised.
Looking inside the flask, the appearance of high-purity 8-Bromo-4-(1H)-Quinazolinone usually matches expectations—it comes as an off-white or slightly beige crystalline powder. The melting point hovers in a region typical for well-structured aromatic systems, avoiding the headaches that sticky or amorphous side-products cause when purifying by crystallization or chromatography. The bromine atom’s presence doesn’t just help in developing reactions either; it also serves as a handy spectroscopic handle for quality control. Proton and carbon NMR, along with LC-MS, show the brominated position clearly, so chemists know they’ve got what they ordered.
Water solubility sits on the low side, as is common for aromatic heterocycles with halogen substitutions. Most researchers dissolve it in polar aprotic solvents like DMSO, DMF, or acetonitrile for assay or reaction screening. The molecular weight, calculated at just over 237 g/mol, is convenient for weighing and dosing in small screening assays. That size fits the ‘lead-like’ space medicinal chemists prefer to start drug optimization programs, avoiding high molecular weights that bring metabolic liabilities.
Several other quinazolinones circulate in both research circles and marketplace catalogs, but none exactly substitute for the bromo version at the 8-position. Chloro, fluoro, or even methyl compounds sometimes get close, but the unique reactivity profile of bromine stands out. Bromine atoms removable under milder conditions than chlorine, yet they’re less labile than iodine, whose heavy atomic mass and handling concerns make it an uneasy addition in many labs. Somewhere on that balance beam, 8-Bromo-4-(1H)-Quinazolinone finds a niche—reactive enough for cross-coupling to work smoothly, not so sensitive as to require gloves-off handling under inert atmosphere all the time.
It’s easy to overlook how subtle differences shape workflow. While 8-chloroquinazolinone shares a similar size and some chemical behaviors, it resists some cross-coupling reactions that work well with the bromo compound. This can save days or even weeks in iterative medicinal chemistry campaigns. I’ve experienced projects stuck for ages on a single step because a chlorine simply did not budge; switching to the bromo analog immediately unlocked new avenues. Lab anecdotes aside, published empirical studies support these observations. Synthesis journals show that bromine intermediates typically yield higher conversion rates in Suzuki-Miyaura and related transformations than their chlorine-laden cousins.
Chemists in both industry and academia slot 8-Bromo-4-(1H)-Quinazolinone into projects that require both precision and flexibility. In drug discovery, the molecule operates as a stepping stone to larger, more complicated entities that interact with enzymes and receptors. The position of the bromine lets biologists and chemists make fine distinctions in their lead optimization campaigns, sometimes deciding the success or failure of a candidate simply by switching a substituent.
Outside traditional pharmaceuticals, crop scientists study quinazolinone derivatives for their roles in growth regulation and pest resistance. Introducing a bromo group changes not only the chemical reactivity, but sometimes also biological properties—such as how quickly a compound moves through soil or how long it persists on leaf surfaces. Analytical chemists use similar derivatives as internal standards in advanced testing workflows. Their distinct mass and spectroscopic signatures allow for easy quantitation in complex samples, like blood plasma or food extracts, reinforcing confidence in assay accuracy.
Material scientists have also begun to leverage these compounds for their electronic and optical properties. Heterocyclic cores serve as building blocks in organic polymers and in the development of new photoactive materials. The strategic bromo group can seed site-selective modifications and tune the physical behavior of polymers, opening the door to creative solutions in wearable tech, environmental sensors, and light-harvesting devices.
Plenty of researchers ask, “Is this compound easy enough to order and use?” Most chemistry suppliers have caught on to the demand and offer 8-Bromo-4-(1H)-Quinazolinone in different pack sizes, reflecting the scale of both exploratory work and late-stage project development. From gram-scale vials for early screening to multigram batches for synthesis, labs now have more flexibility and access than ever. With purity grades clearly specified and batch-to-batch variation rare from established suppliers, project managers don’t get sidelined by unanticipated material issues.
Long-term storage usually just means keeping it dry and cool, much as with other aromatic compounds. Its thermal stability stays within comfortable ranges for normal laboratory glassware, not requiring any special containment or controlled-atmosphere handling for everyday research. For larger-scale users, safety data reveal only moderate hazards, in line with most aromatic halides. Most teams still review material safety data sheets regularly and follow standard chemical hygiene best practices, including glove use and good ventilation, but those are facts of lab life.
I’ve learned from experience that having immediate access to robust building blocks like this can mean the difference between weeks lost to synthetic troubleshooting and days spent progressing toward publishable or patentable results. For labs pressed for time, or for researchers tackling a diverse set of biological targets, that reliability is worth more than the marginal extra cost over generic alternatives.
No product comes without challenges. For 8-Bromo-4-(1H)-Quinazolinone, the biggest issues aren’t with the material itself but arise from the need to source from reputable vendors. The surge in demand over recent years has attracted newer, sometimes less scrupulous suppliers. Occasionally, stories circulate about off-spec batches, showing lower purity or containing similar-looking contaminants that don’t reveal themselves until later analysis, disrupting synthesis or biological evaluations.
The solution starts with a robust vetting process: established vendors typically provide full analytical data, including NMR, HPLC, and mass spectrometry, detailing their batch’s purity and identity. Labs developing their own APIs turn to repeat suppliers with strong quality control, and sometimes run in-house checks before investing time and resources in larger-scale chemistry. Transparency in sourcing—and not just a low price—keeps an ambitious pipeline on track.
Handling aromatic bromides carries certain environmental and safety implications. Regulatory climates keep tightening around the use of halogenated organics, especially in Europe and East Asia. Proper waste disposal becomes more critical. Chemists and lab managers take extra care to neutralize and collect waste streams rather than dumping them down the sink, both for safety and legal compliance. Many labs now favor green chemistry approaches, carefully choosing solvents and reaction conditions that minimize hazardous byproducts, and look for recycling schemes whenever possible.
Maintaining high standards and regular internal communication avoids surprises. A junior researcher once misread a bottle label, mistaking 8-bromo for the less reactive 8-chloro derivative, only realizing the error after a failed cross-coupling and several days lost. Digital inventory systems and regular training help prevent such mix-ups. Some research environments now require barcode-based registration of all chemicals upon entering the lab, improving traceability and reducing inventory headaches. While not unique to this compound, proper handling and storage always pay dividends down the line.
From the first wave of quinazolinone drugs in the 1960s to genome-guided new drug design today, the core structure hasn’t faded from favor. Rather than being a holdover from the past, modern derivatives like 8-Bromo-4-(1H)-Quinazolinone illustrate how refinements to a proven structure drive new possibilities in discovery. The strategic placement of a bromo atom feeds directly into workflow improvements: chemists get to try more building blocks, biologists see sharper SAR (structure-activity relationship) data, and decision-makers move compounds forward—or kill off dead ends—more efficiently.
Libraries of kinase inhibitors almost always contain several quinazolinone analogs, because they mimic ATP-binding regions in enzymes, fitting into biological pockets that resist less flexible scaffolds. The bromo derivative raises the game by introducing unique vectors for expanding a molecule’s reach, letting researchers ‘dial in’ changes in activity or selectivity. These fine-tuned analogs sometimes uncover hidden efficacy in resistant disease models, pointing researchers to fresh mechanistic insights.
Beyond pharmaceuticals, chemical biologists increasingly use such building blocks for designing molecular probes and imaging agents. Tinkering with the quinazolinone core lets specialists attach fluorescent tags, chelating cores, or biotin handles specifically at the bromo position, thanks to the underlying reactivity. Scientists map protein interactions or visualize live cellular responses with molecular precision tied back to the chemistry of their starting blocks.
Science marches on the shoulders of such foundational molecules. As AI and automated synthetic planning become standard in research, building blocks like 8-Bromo-4-(1H)-Quinazolinone look set to take on even greater importance. Rather than chasing every new scaffold, teams with access to reactive, high-quality intermediates can iterate faster, pivoting from lead identification to late-stage optimization with fewer false starts.
The rise of high-throughput experimentation (HTE) has thrown open doors for libraries of derivatives. Automated reaction platforms process dozens of substrates at once, and the availability of reactive positions on simple scaffolds gives researchers the power to screen for hits in days rather than months. In this fast-moving environment, quinazolinone derivatives with strategic halogenation punch above their weight.
As regulations shift, particularly around environmental impact, the community will rely on suppliers who offer both quality and traceability. Advances in bromine recovery and halide recycling should help lower the ecological footprint. The goal remains simple: maximize research impact, minimize waste, and keep safety top of mind.
After years working with many building blocks, I’ve seen the difference that smart, accessible intermediates make to both lab workflow and scientific output. 8-Bromo-4-(1H)-Quinazolinone stands out for its blend of robust functionality and strategic reactivity. Chemists gain flexibility in designing synthetic pathways, biologists get molecules that probe new biological space, and materials scientists discover fresh applications. Its reliable purity, broad commercial availability, and adaptability to modern research needs make it a backbone for current and future discovery. With trusted sourcing and careful handling, this compound will keep delivering value across the spectrum of chemical research, both as a tool and as catalyst for new breakthroughs.